Moraxella catarrhalis is contagious. It spreads through respiratory droplets and direct close contact, much like the common cold. However, the full picture is more nuanced than a simple yes or no: this bacterium lives harmlessly in the nose and throat of a large percentage of healthy people, especially children, and only causes illness under certain conditions.
How It Spreads
Moraxella catarrhalis travels from person to person through respiratory secretion droplets (coughing, sneezing, talking) and through direct close contact. Sharing utensils, kissing, or touching contaminated surfaces and then touching your nose or mouth are all plausible routes. This makes it behave like many other common respiratory bacteria.
What makes this bacterium different from, say, the flu virus is that “catching” it doesn’t necessarily mean getting sick. Many people carry it in their upper airways without any symptoms at all. Spread is most likely in settings where people are in close quarters: daycares, households with young children, and nursing facilities.
Colonization vs. Infection
One of the most important things to understand about this bacterium is the distinction between colonization and infection. Colonization means the bacteria are present in your nose and throat but aren’t causing any problems. Infection means they’ve moved beyond their usual spot and are actively causing disease.
Colonization rates are remarkably high. Studies estimate that 26% to 77% of healthy children worldwide carry Moraxella catarrhalis in their nasopharynx at any given time. Adults carry it too, though at lower rates. Most of these carriers will never develop symptoms. The bacterium sits quietly as part of the normal bacterial community in the upper respiratory tract.
Problems start when the bacteria migrate from the nasopharynx to other areas. From that colonization site, the organism can spread directly into the middle ear (causing ear infections), into the sinuses, or down into the lungs. In rare cases, it can enter the bloodstream.
Who Gets Sick
Children under five are the most commonly affected group. Moraxella catarrhalis is the third leading bacterial cause of middle ear infections in young kids, behind only two other common respiratory bacteria. It also frequently causes sinus infections in this age group. Most otherwise healthy children recover without complications.
In adults, the bacterium poses the greatest threat to people with chronic obstructive pulmonary disease (COPD). A previous Moraxella catarrhalis infection is a powerful risk factor for COPD flare-ups requiring hospitalization. One study found the odds of rehospitalization were dramatically higher in COPD patients with a history of this infection compared to those without, particularly when combined with severe airflow limitation. For people with COPD, this isn’t a minor nuisance; it can trigger serious worsening of their breathing.
Other groups at elevated risk include older adults, people with weakened immune systems, smokers, and anyone with chronic lung conditions beyond COPD.
What Symptoms Look Like
There’s no single telltale sign that distinguishes a Moraxella catarrhalis infection from infections caused by other respiratory bacteria. The symptoms depend entirely on where in the body the infection takes hold.
- Ear infections: ear pain, fever, irritability in young children, sometimes fluid draining from the ear.
- Sinus infections: facial pressure, nasal congestion, thick nasal discharge, headache.
- Lower respiratory infections: worsening cough, thicker and discolored mucus, and increased shortness of breath. These are particularly common in adults with existing lung disease.
Because the symptoms overlap with infections from other bacteria and even viruses, lab testing is the only way to confirm Moraxella catarrhalis as the specific cause. Doctors typically use a bacterial culture from a swab or sputum sample, which remains the standard method. Faster molecular tests can identify the bacterium within about two hours when speed matters.
The Incubation and Contagious Period
Here’s an honest gap in the science: the exact incubation period for Moraxella catarrhalis is unknown. Neither the time from exposure to symptom onset nor the precise window during which someone can pass the infection to others has been clearly defined. The American Academy of Pediatrics notes that the duration of carriage and the period of communicability remain undetermined.
This uncertainty exists partly because colonization is so common and usually harmless. It’s difficult to pinpoint exactly when someone “caught” a bacterium that a large portion of the population already carries. For practical purposes, it’s reasonable to assume that someone with an active respiratory infection is more likely to spread the bacteria than a healthy carrier, since coughing and sneezing generate far more droplets.
Treatment and Antibiotic Resistance
Most Moraxella catarrhalis infections are treated with antibiotics, but the choice of antibiotic matters. Over 95% of strains worldwide now produce an enzyme that breaks down penicillin-type antibiotics, making standard penicillin ineffective. This resistance developed gradually over decades and is now nearly universal.
Doctors typically prescribe antibiotics that can withstand this enzyme or use alternative drug classes. Resistance to other antibiotic families is also emerging, driven by widespread use of oral antibiotics for respiratory infections. This trend is a growing concern, though for now most infections still respond well to the right treatment.
For mild ear or sinus infections, especially in children, some cases resolve on their own. Your doctor may recommend a watch-and-wait approach for a day or two before starting antibiotics, depending on the severity of symptoms and the child’s age.
Reducing Your Risk of Spread
Because Moraxella catarrhalis spreads through the same routes as colds and flu, the prevention strategies are familiar. Regular handwashing, covering coughs and sneezes, and cleaning shared surfaces all reduce transmission. Keeping sick children home from daycare limits spread in the setting where it’s most common.
During the COVID-19 pandemic, masking and social distancing measures significantly reduced Moraxella catarrhalis infections in children, confirming that droplet-based precautions work. There is no vaccine against this bacterium, so basic hygiene remains the primary line of defense.